Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
Clinical trial NCT05984004 · COMPLETED
Trial details
- NCT number
- NCT05984004
- Sponsor
- Huro Biotech Joint Stock Company
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2022-11-22
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.